» Articles » PMID: 27094723

Suppression of MicroRNA-125a-5p Upregulates the TAZ-EGFR Signaling Pathway and Promotes Retinoblastoma Proliferation

Overview
Journal Cell Signal
Date 2016 Apr 21
PMID 27094723
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Retinoblastoma is the most common intraocular malignancy that occurs during childhood; however, the mechanism underlying retinoblastoma proliferation and progression remains unclear. MicroRNAs (miRNAs) play an important role in the regulation of a myriad of biological processes in various types of cancer. In this study, we performed microarray analysis followed by qRT-PCR using four classes of retinoblastoma tissues with increasing cTNM classification stages to identify crucial miRNAs whose expression was correlated with retinoblastoma progression. miR-125a-5p was downregulated, and its expression levels were inversely correlated with cell proliferation in retinoblastoma compared with adjacent non-tumor retinal tissues. The overexpression of miR-125a-5p significantly suppressed cell proliferation and tumor formation in retinoblastoma. We further identified the transcriptional co-activator with PDZ binding motif (TAZ) as a direct target of miR-125a-5p. Importantly, TAZ levels were inversely correlated with miRNA-125a-5p expression, and TAZ promoted retinoblastoma cell proliferation. Moreover, the overexpression of miR-125a-5p led to a decrease in TAZ expression and downstream EGFR signaling pathway activation both in vitro and vivo. Finally, TAZ overexpression in retinoblastoma cells overexpressing miR-125a-5p restored retinoblastoma cell proliferation and EGFR pathway activation. Taken together, our data demonstrated that miR-125a-5p functions as an important tumor suppressor that suppresses the EGFR pathway by targeting TAZ to inhibit tumor progression in retinoblastoma. Thus, the miR-125a-5p/TAZ/EGFR axis may be a potential therapeutic target for retinoblastoma.

Citing Articles

miRNA changes associated with differentiation of human embryonic stem cells into human retinal ganglion cells.

Esmaeili M, Smith D, Mead B Sci Rep. 2024; 14(1):31895.

PMID: 39738601 PMC: 11685716. DOI: 10.1038/s41598-024-83381-9.


Interaction of noncoding RNAs with hippo signaling pathway in cancer cells and cancer stem cells.

Abedimanesh S, Safaralizadeh R, Jahanafrooz Z, Najafi S, Amini M, Nazarloo S Noncoding RNA Res. 2024; 9(4):1292-1307.

PMID: 39045083 PMC: 11263728. DOI: 10.1016/j.ncrna.2024.06.006.


The Hippo signalling pathway and its impact on eye diseases.

Du Y J Cell Mol Med. 2024; 28(8):e18300.

PMID: 38613348 PMC: 11015399. DOI: 10.1111/jcmm.18300.


Hippo-YAP/TAZ signaling in breast cancer: Reciprocal regulation of microRNAs and implications in precision medicine.

Sadri F, Hosseini S, Rezaei Z, Fereidouni M Genes Dis. 2023; 11(2):760-771.

PMID: 37692482 PMC: 10491881. DOI: 10.1016/j.gendis.2023.01.017.


MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?.

Yang H, Liu Y, Chen L, Zhao J, Guo M, Zhao X Biomolecules. 2023; 13(6).

PMID: 37371458 PMC: 10295928. DOI: 10.3390/biom13060877.